Drug Topics E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Modern Medicine Network
  Drug Topics E-News
 
JULY 21 , 2009
IN THIS ISSUE
Court says dispense Plan B
Tough year for retail
PCIDs update
FDA OKs generic Plan B
  TOP SEARCHES: CE // Diabetes // Vertex

Pharmacists required to dispense Plan B
Pharmacists are expected to dispense the Plan B pill, regardless of their personal opinions about the "morning after" contraceptive or any religious beliefs against dispensing it, a federal appeals court ruled Wednesday.
More...

Analysts bearish on retail pharmacies
The outlook for retail pharmacy chains throughout 2009 is negative, according to Zacks Equity Research in Chicago, Ill. In fact, the investment research firm currently has a “sell” rating on Rite Aid stock and a “hold” rating on CVS/pharmacy and Walgreens. More...

FDA issues guidance on PCIDs
The Food and Drug Administration has issued a draft guidance on the use of inks, pigments, flavors, and other physical-chemical identifiers (PCIDs) employed by manufacturers to make drug products more difficult to duplicate by counterfeiters and to make it easier to identify a genuine version of a drug. More...

Generic Plan B approved by FDA
The Food and Drug Administration has approved the first generic version of the 0.75 mg Plan B emergency contraceptive tablets. For women ages 17 and under, levonorgestrel, the generic product, will be available by prescription only. More...


Key Topic Updates
Issues & Trends
 
Professional
 
Clinical
 
Technology
 
Regulatory & Law

 

Key Topic Updates

Survey
What do you spend the most time counseling customers on?
OTC medications   58%
Painkillers   13%
Adverse drug reactions 20%
Other 9%

This month we would like to know...

Is direct-to-consumer advertising a good idea?

Yes
NO

Click here to vote


Contact Us
Click here to learn more about the Drug Topics editorial team.

Click here to contact the Drug Topics editorial team.

Click here to contact the Drug Topics sales team.

Click here to learn about direct mail, reprints and classifieds in Drug Topics.

Drug Topics Digital Edition
Click here to to view the most recent issue.

Click here to subscribe.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.